Switch theme
Sign up to access all valuation multiples
Green Thumb Industries is headquartered in Chicago, Illinois, and produces and sells medicinal and recreational cannabis through wholesale and retail channels in the United States. It has a presence in 14 states and operates more than 100 cannabis stores under the brand Rise. GTI is focusing its expansion on limited license states with large populations, and it does not currently export into the global medical market due to US federal prohibition. It offers multiple products under a portfolio of cannabis consumer packaged goods brands, including &Shine, Beboe, Dogwalkers, Doctor Solomon’s, Good Green, incredibles, and RYTHM.
2002
4.8K+
LTM Revenue $1.6B
LTM EBITDA $499M
$1.7B
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Green Thumb Indus has a last 12-month revenue (LTM) of $1.6B and a last 12-month EBITDA of $499M.
In the most recent fiscal year, Green Thumb Indus achieved revenue of $836M and an EBITDA of $288M.
Green Thumb Indus expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Green Thumb Indus valuation multiples based on analyst estimates| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue | $1.6B | XXX | $836M | XXX | XXX | XXX |
| Gross Profit | $829M | XXX | $442M | XXX | XXX | XXX |
| Gross Margin | 52% | XXX | 53% | XXX | XXX | XXX |
| EBITDA | $499M | XXX | $288M | XXX | XXX | XXX |
| EBITDA Margin | 31% | XXX | 34% | XXX | XXX | XXX |
| EBIT | $283M | XXX | $165M | XXX | XXX | XXX |
| EBIT Margin | 18% | XXX | 20% | XXX | XXX | XXX |
| Net Profit | $77.7M | XXX | $53.7M | XXX | XXX | XXX |
| Net Margin | 5% | XXX | 6% | XXX | XXX | XXX |
| Net Debt | XXX | XXX | $61.2M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of July 18, 2025, Green Thumb Indus's stock price is CAD 8 (or $6).
Green Thumb Indus has current market cap of CAD 1.8B (or $1.3B), and EV of CAD 2.3B (or $1.7B).
See Green Thumb Indus trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $1.7B | $1.3B | XXX | XXX | XXX | XXX | $0.23 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of July 18, 2025, Green Thumb Indus has market cap of $1.3B and EV of $1.7B.
Green Thumb Indus's trades at 2.0x EV/Revenue multiple, and 5.8x EV/EBITDA.
Equity research analysts estimate Green Thumb Indus's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Green Thumb Indus has a P/E ratio of 23.5x.
See valuation multiples for Green Thumb Indus and 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $1.3B | XXX | $1.3B | XXX | XXX | XXX |
| EV (current) | $1.7B | XXX | $1.7B | XXX | XXX | XXX |
| EV/Revenue | 1.4x | XXX | 2.0x | XXX | XXX | XXX |
| EV/EBITDA | 4.5x | XXX | 5.8x | XXX | XXX | XXX |
| EV/EBIT | 8.0x | XXX | 10.1x | XXX | XXX | XXX |
| EV/Gross Profit | 2.7x | XXX | n/a | XXX | XXX | XXX |
| P/E | 23.5x | XXX | 25.0x | XXX | XXX | XXX |
| EV/FCF | 14.4x | XXX | 19.6x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialGreen Thumb Indus's last 12 month revenue growth is 2%
Green Thumb Indus's revenue per employee in the last FY averaged $0.2M, while opex per employee averaged $0.1M for the same period.
Green Thumb Indus's rule of 40 is 32% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Green Thumb Indus's rule of X is 35% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for Green Thumb Indus and other 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 2% | XXX | 21% | XXX | XXX | XXX |
| EBITDA Margin | 31% | XXX | 34% | XXX | XXX | XXX |
| EBITDA Growth | -2% | XXX | 20% | XXX | XXX | XXX |
| Rule of 40 | 32% | XXX | 36% | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | 35% | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | $0.2M | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | $0.1M | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | 33% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Live Verdure | XXX | XXX | XXX | XXX | XXX | XXX |
| Ascend Wellness Holdings | XXX | XXX | XXX | XXX | XXX | XXX |
| Ayr Wellness | XXX | XXX | XXX | XXX | XXX | XXX |
| Cresco Labs | XXX | XXX | XXX | XXX | XXX | XXX |
| Grown Rogue | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Green Thumb Indus acquired XXX companies to date.
Last acquisition by Green Thumb Indus was XXXXXXXX, XXXXX XXXXX XXXXXX . Green Thumb Indus acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free Trial| When was Green Thumb Indus founded? | Green Thumb Indus was founded in 2002. |
| Where is Green Thumb Indus headquartered? | Green Thumb Indus is headquartered in Canada. |
| How many employees does Green Thumb Indus have? | As of today, Green Thumb Indus has 4.8K+ employees. |
| Is Green Thumb Indus publicy listed? | Yes, Green Thumb Indus is a public company listed on CNQ. |
| What is the stock symbol of Green Thumb Indus? | Green Thumb Indus trades under GTII ticker. |
| When did Green Thumb Indus go public? | Green Thumb Indus went public in 1987. |
| Who are competitors of Green Thumb Indus? | Similar companies to Green Thumb Indus include e.g. Live Verdure, Ascend Wellness Holdings, Ayr Wellness, Cresco Labs. |
| What is the current market cap of Green Thumb Indus? | Green Thumb Indus's current market cap is $1.3B |
| What is the current revenue of Green Thumb Indus? | Green Thumb Indus's last 12 months revenue is $1.6B. |
| What is the current revenue growth of Green Thumb Indus? | Green Thumb Indus revenue growth (NTM/LTM) is 2%. |
| What is the current EV/Revenue multiple of Green Thumb Indus? | Current revenue multiple of Green Thumb Indus is 1.4x. |
| Is Green Thumb Indus profitable? | Yes, Green Thumb Indus is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Green Thumb Indus? | Green Thumb Indus's last 12 months EBITDA is $499M. |
| What is Green Thumb Indus's EBITDA margin? | Green Thumb Indus's last 12 months EBITDA margin is 31%. |
| What is the current EV/EBITDA multiple of Green Thumb Indus? | Current EBITDA multiple of Green Thumb Indus is 4.5x. |
| What is the current FCF of Green Thumb Indus? | Green Thumb Indus's last 12 months FCF is $157M. |
| What is Green Thumb Indus's FCF margin? | Green Thumb Indus's last 12 months FCF margin is 10%. |
| What is the current EV/FCF multiple of Green Thumb Indus? | Current FCF multiple of Green Thumb Indus is 14.4x. |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
